1348 related articles for article (PubMed ID: 27799412)
1. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
[TBL] [Abstract][Full Text] [Related]
2. Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.
Melnikow J; Fenton JJ; Whitlock EP; Miglioretti DL; Weyrich MS; Thompson JH; Shah K
Ann Intern Med; 2016 Feb; 164(4):268-78. PubMed ID: 26757021
[TBL] [Abstract][Full Text] [Related]
3. Identifying women with dense breasts at high risk for interval cancer: a cohort study.
Kerlikowske K; Zhu W; Tosteson AN; Sprague BL; Tice JA; Lehman CD; Miglioretti DL;
Ann Intern Med; 2015 May; 162(10):673-81. PubMed ID: 25984843
[TBL] [Abstract][Full Text] [Related]
4. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Kerlikowske K; Zhu W; Su YR; Sprague BL; Stout NK; Onega T; O'Meara ES; Henderson LM; Tosteson ANA; Wernli K; Miglioretti DL
J Natl Cancer Inst; 2024 Feb; 116(2):249-257. PubMed ID: 37897090
[TBL] [Abstract][Full Text] [Related]
5. Impact of the New Jersey Breast Density Law on Imaging and Intervention Volumes and Breast Cancer Diagnosis.
Sanders LM; King AB; Goodman KS
J Am Coll Radiol; 2016 Oct; 13(10):1189-1194. PubMed ID: 27318582
[TBL] [Abstract][Full Text] [Related]
6. Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer.
Kerlikowske K; Su YR; Sprague BL; Tosteson ANA; Buist DSM; Onega T; Henderson LM; Alsheik N; Bissell MCS; O'Meara ES; Lee CI; Miglioretti DL
JAMA; 2022 Jun; 327(22):2220-2230. PubMed ID: 35699706
[TBL] [Abstract][Full Text] [Related]
7. Supplemental Breast Imaging Utilization After Breast Density Legislation in North Carolina.
Nyante SJ; Marsh MW; Benefield T; Earnhardt K; Lee SS; Henderson LM
J Am Coll Radiol; 2020 Jan; 17(1 Pt A):6-14. PubMed ID: 31271735
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.
Brandt KR; Scott CG; Ma L; Mahmoudzadeh AP; Jensen MR; Whaley DH; Wu FF; Malkov S; Hruska CB; Norman AD; Heine J; Shepherd J; Pankratz VS; Kerlikowske K; Vachon CM
Radiology; 2016 Jun; 279(3):710-9. PubMed ID: 26694052
[TBL] [Abstract][Full Text] [Related]
9. Breast Density Notification Legislation and Breast Cancer Stage at Diagnosis: Early Evidence from the SEER Registry.
Richman I; Asch SM; Bendavid E; Bhattacharya J; Owens DK
J Gen Intern Med; 2017 Jun; 32(6):603-609. PubMed ID: 27844260
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic differences in supplemental imaging for breast cancer screening in women with dense breasts.
Ezratty C; Vang S; Brown J; Margolies LR; Jandorf L; Lin JJ
Breast Cancer Res Treat; 2020 Jul; 182(1):181-185. PubMed ID: 32394349
[TBL] [Abstract][Full Text] [Related]
11. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41.
Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE
Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501
[TBL] [Abstract][Full Text] [Related]
12. Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification.
Smith RE; Sprague B; Henderson LM; Kerlikowske K; Miglioretti DL; Buist DSM; Wernli KJ; Onega T; Schifferdecker K; Jackson-Nefertiti G; Johnson D; Budesky J; Tosteson ANA
J Am Coll Radiol; 2022 May; 19(5):615-624. PubMed ID: 35341697
[TBL] [Abstract][Full Text] [Related]
13. Quantification of masking risk in screening mammography with volumetric breast density maps.
Holland K; van Gils CH; Mann RM; Karssemeijer N
Breast Cancer Res Treat; 2017 Apr; 162(3):541-548. PubMed ID: 28161786
[TBL] [Abstract][Full Text] [Related]
14. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM
Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124
[TBL] [Abstract][Full Text] [Related]
15. Impact of the California Breast Density Law on Screening Breast MR Utilization, Provider Ordering Practices, and Patient Demographics.
Ram S; Sarma N; López JE; Liu Y; Li CS; Aminololama-Shakeri S
J Am Coll Radiol; 2018 Apr; 15(4):594-600. PubMed ID: 29622173
[TBL] [Abstract][Full Text] [Related]
16. The impact of legislation mandating breast density notification - Review of the evidence.
Houssami N; Lee CI
Breast; 2018 Dec; 42():102-112. PubMed ID: 30236594
[TBL] [Abstract][Full Text] [Related]
17. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
18. Breast Cancer Risk and Mammographic Density Assessed with Semiautomated and Fully Automated Methods and BI-RADS.
Jeffers AM; Sieh W; Lipson JA; Rothstein JH; McGuire V; Whittemore AS; Rubin DL
Radiology; 2017 Feb; 282(2):348-355. PubMed ID: 27598536
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
